PRLDPrelude Therapeutics Incorporated
6.630USD+14.71%Mkt Cap: 528.05M $P/E: —3d ago
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing JAK2V617F, a driver m…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap528.05M $
Enterprise Value535.36M $
Revenue (TTM)22.42M $
Gross Profit22.42M $
Net Income (TTM)-99.50M $
Revenue/Share0.2660 USD
Last Price6.630 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees79
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.67
PEG—
EV/EBITDA-8.30
EV/Revenue23.87
P/S23.13
P/B5.00
EPS (TTM)-0.82
EPS (Forward)-0.75
52W Range
0.832097% of range6.816
52W High6.816 USD
52W Low0.8320 USD
Profitability
Gross Margin100.00%
Oper. Margin-270.93%
EBITDA Margin-287.68%
Profit Margin-819.59%
ROE-144.96%
ROA-70.41%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-56.30M $
CapEx (TTM)67.00K $
FCF Margin-61.74%
FCF Yield-2.62%
Net Debt-134.11M $
Net Debt/EBITDA2.08
Balance Sheet
Debt/Equity0.26
Current Ratio4.07
Quick Ratio3.99
Book Value/Sh1.299 USD
Cash/Share1.473 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.000 USD
Upside (mean)+20.7%
Target Range6.000 USD – 10.00 USD
$6.000+20.7% to mean$10.00
# Analysts3
Ownership
Shares Out.64.92M
Float22.07M
Insiders13.76%
Institutions76.46%
Short Interest
Short Ratio9.3d
Short % Float14.59%
Short % Out.4.61%
Shares Short3.67M
Short (prev mo.)2.82M
Technical
SMA 504.681 (+41.6%)
SMA 2003.384 (+95.9%)
Beta0.94
S&P 52W Chg18.16%
Avg Vol (30d)384.06K
Avg Vol (10d)643.39K
Technical Indicators
RSI (14)74.8
MACD0.4159
MACD Signal0.2515
MACD Hist.+0.1644
BB Upper6.354 USD
BB Middle4.926 USD
BB Lower3.497 USD
BB Width58.01%
ATR (14)0.4628 USD
Vol Ratio (20d)1.23x